FBXW7 and cancer: To test the impact of FBXW7 deficiency in the response to cancer therapies, we generated Fbxw7 wild‐type (WT) and knockout mES cell lines by CRISPR editing (Appendix Fig S2A), which constitutively expressed the fluorescent proteins EGFP or RUBY3, respectively.